Real-time enrollment status for this long term safety following gm t cell therapy clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 1:44 AM UTC
| NCT Number | NCT06798298 |
| Recruiting Status | Recruiting |
| Condition | Long Term Safety Following GM T Cell Therapy |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | July 8, 2026 (6 days ago) |
As of July 14, 2026: Clinical trial NCT06798298 is currently recruiting participants. This clinical trial study for long term safety following gm t cell therapy is actively seeking new participants at 1 location across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06798298 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06798298 was last updated 6 days ago (July 8, 2026). HelloStudys verifies this status automatically.